Literature DB >> 23247891

The sensitivity and specificity of the mood disorders questionnaire varies with the intensity of mood illness.

Karthik S Suresh1, R Jeannie Roberts, Rif S El-Mallakh.   

Abstract

The Mood Disorders Questionnaire (MDQ) is a tool that was created for screening for bipolar disorders. This study investigates the utility of the MDQ in an acute psychiatric in-patient setting. All patients admitted to an acute inpatient psychiatric unit completed the MDQ. Discharge diagnoses strictly followed DSM-IV criteria, but were determined through clinical interviews, collateral information, and psychiatric history, and were used to calculate the sensitivity and specificity of the MDQ in this setting. 44 subjects were admitted during the study period; 42 completed the MDQ. 12 had bipolar illness. Sensitivity of MDQ was 0.58, and specificity was 0.76 (P < 0.05). Positive predictive value was 0.50 and negative predictive value was 0.82. The specificity and sensitivity of the MDQ appears to vary with the illness severity of the patients screened.

Entities:  

Mesh:

Year:  2013        PMID: 23247891     DOI: 10.1007/s11126-012-9249-8

Source DB:  PubMed          Journal:  Psychiatr Q        ISSN: 0033-2720


  11 in total

1.  Validity of the mood disorder questionnaire: a general population study.

Authors:  Robert M A Hirschfeld; Charles Holzer; Joseph R Calabrese; Myrna Weissman; Michael Reed; Marilyn Davies; Mark A Frye; Paul Keck; Susan McElroy; Lydia Lewis; Jonathan Tierce; Karen D Wagner; Elizabeth Hazard
Journal:  Am J Psychiatry       Date:  2003-01       Impact factor: 18.112

Review 2.  Improving the diagnosis of bipolar disorder: predictive value of screening tests.

Authors:  James R Phelps; S Nassir Ghaemi
Journal:  J Affect Disord       Date:  2006-03-09       Impact factor: 4.839

3.  Development and validation of a screening instrument for bipolar spectrum disorder: the Mood Disorder Questionnaire.

Authors:  R M Hirschfeld; J B Williams; R L Spitzer; J R Calabrese; L Flynn; P E Keck; L Lewis; S L McElroy; R M Post; D J Rapport; J M Russell; G S Sachs; J Zajecka
Journal:  Am J Psychiatry       Date:  2000-11       Impact factor: 18.112

4.  Use of health care services among persons who screen positive for bipolar disorder.

Authors:  Mark A Frye; Joseph R Calabrese; Michael L Reed; Karen Dineen Wagner; Lydia Lewis; James McNulty; Robert M A Hirschfeld
Journal:  Psychiatr Serv       Date:  2005-12       Impact factor: 3.084

5.  Diagnosing bipolar disorder and the effect of antidepressants: a naturalistic study.

Authors:  S N Ghaemi; E E Boiman; F K Goodwin
Journal:  J Clin Psychiatry       Date:  2000-10       Impact factor: 4.384

6.  Impact of depressive symptoms compared with manic symptoms in bipolar disorder: results of a U.S. community-based sample.

Authors:  Joseph R Calabrese; Robert M A Hirschfeld; Mark A Frye; Michael L Reed
Journal:  J Clin Psychiatry       Date:  2004-11       Impact factor: 4.384

7.  Impact of bipolar disorder on a U.S. community sample.

Authors:  Joseph R Calabrese; Robert M A Hirschfeld; Michael Reed; Marilyn A Davies; Mark A Frye; Paul E Keck; Lydia Lewis; Susan L McElroy; James P McNulty; Karen D Wagner
Journal:  J Clin Psychiatry       Date:  2003-04       Impact factor: 4.384

8.  Diagnostic reliability of the history of hypomania in bipolar II patients and patients with major depression.

Authors:  D L Dunner; L K Tay
Journal:  Compr Psychiatry       Date:  1993 Sep-Oct       Impact factor: 3.735

9.  Clinical predictors of unrecognized bipolar I and II disorders.

Authors:  Outi Mantere; Kirsi Suominen; Petri Arvilommi; Hanna Valtonen; Sami Leppämäki; Erkki Isometsä
Journal:  Bipolar Disord       Date:  2008-03       Impact factor: 6.744

10.  Perceptions and impact of bipolar disorder: how far have we really come? Results of the national depressive and manic-depressive association 2000 survey of individuals with bipolar disorder.

Authors:  Robert M A Hirschfeld; Lydia Lewis; Lana A Vornik
Journal:  J Clin Psychiatry       Date:  2003-02       Impact factor: 4.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.